Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus

• Published in: Journal of virology 2020-08, Vol.94 (18)
• Main Authors: Thomas, Ashlie, Thiono, Devina J, Kudlacek, Stephan T, Forsberg, John, Premkumar, Lakshmanane, Tian, Shaomin, Kuhlman, Brian, de Silva, Aravinda M, Metz, Stefan W
• Format: Article
• Language: English
• Subjects: Animals; Antibodies, Monoclonal - biosynthesis; Antibodies, Viral - biosynthesis; Antibody-Dependent Enhancement; Chlorocebus aethiops; Cross Reactions; Dengue - immunology; Dengue - pathology; Dengue - prevention & control; Dengue - virology; Dengue Vaccines - administration & dosage; Dengue Vaccines - genetics; Dengue Vaccines - immunology; Dengue Virus - drug effects; Dengue Virus - genetics; Dengue Virus - immunology; Disease Models, Animal; Epitopes - chemistry; Epitopes - genetics; Epitopes - immunology; Female; HEK293 Cells; Humans; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Protein Isoforms - administration & dosage; Protein Isoforms - genetics; Protein Isoforms - immunology; Protein Multimerization - drug effects; Spotlight; Vaccination - methods; Vaccines and Antiviral Agents; Vaccines, Subunit; Vero Cells; Viral Envelope Proteins - administration & dosage; Viral Envelope Proteins - genetics; Viral Envelope Proteins - immunology
• ISSN: 0022-538X; 1098-5514; 1098-5514
• DOI: 10.1128/JVI.00745-20

Dengue virus (DENV) is responsible for the most prevalent and significant arthropod-borne viral infection of humans. The leading DENV vaccines are based on tetravalent live-attenuated virus platforms. In practice, it has been challenging to induce balanced and effective responses to each of the four DENV serotypes because of differences in the replication efficiency and immunogenicity of individual vaccine components. Unlike live vaccines, tetravalent DENV envelope (E) protein subunit vaccines are likely to stimulate balanced immune responses, because immunogenicity is replication independent. However, E protein subunit vaccines have historically performed poorly, in part because the antigens utilized were mainly monomers that did not display quaternary-structure epitopes found on E dimers and higher-order structures that form the viral envelope. In this study, we compared the immunogenicity of DENV2 E homodimers and DENV2 E monomers. The stabilized DENV2 homodimers, but not monomers, were efficiently recognized by virus-specific and flavivirus cross-reactive potently neutralizing antibodies that have been mapped to quaternary-structure epitopes displayed on the viral surface. In mice, the dimers stimulated 3-fold-higher levels of virus-specific neutralizing IgG that recognized epitopes different from those recognized by lower-level neutralizing antibodies induced by monomers. The dimer induced a stronger E domain I (EDI)- and EDII-targeted response, while the monomer antigens stimulated an EDIII epitope response and induced fusion loop epitope antibodies that are known to facilitate antibody-dependent enhancement (ADE). This study shows that DENV E subunit antigens that have been designed to mimic the structural organization of the viral surface are better vaccine antigens than E protein monomers. Dengue virus vaccine development is particularly challenging because vaccines have to provide protection against four different dengue virus stereotypes. The leading dengue virus vaccine candidates in clinical testing are all based on live-virus vaccine platforms and struggle to induce balanced immunity. Envelope subunit antigens have the potential to overcome these limitations but have historically performed poorly as vaccine antigens, because the versions tested previously were presented as monomers and not in their natural dimer configuration. This study shows that the authentic presentation of DENV2 E-based subunits has a strong impact on antibody responses,